Showing results (271-280 of 310) with videos related to

Sort By:
Pageof 31
Hepatology Research : the Official Journal of the Japan Society of Hepatology|August 26, 2018
Therapeutic potential of lenvatinib for unresectable hepatocellular carcinoma in clinical practice: Multicenter analysisAtsushi Hiraoka, Takashi Kumada, Kazuya Kariyama, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|May 16, 2012
Complications of radiofrequency ablation for hepatocellular carcinoma in a multicenter study: An analysis of 16 346 treated nodules in 13 283 patientsMasahiko Koda, Yoshikazu Murawaki, Yasuaki Hirooka, et al.
Cancer Medicine|December 22, 2018
Clinical features of lenvatinib for unresectable hepatocellular carcinoma in real-world conditions: Multicenter analysisAtsushi Hiraoka, Takashi Kumada, Kazuya Kariyama, et al.
Cancer Medicine|May 24, 2022
The prognosis of elderly patients with hepatocellular carcinoma: A multi-center 19-year experience in JapanTakeshi Hatanaka, Satoru Kakizaki, Atsushi Hiraoka, et al.
Nucleic Acids Research|May 9, 2023
Crucial role of iron in epigenetic rewriting during adipocyte differentiation mediated by JMJD1A and TET2 activityTomohiro Suzuki, Tetsuro Komatsu, Hiroshi Shibata, et al.
Shokuhin Eiseigaku Zasshi. Journal of the Food Hygienic Society of Japan|July 4, 2014
[Interlaboratory study on migration test of cadmium and lead for food contact articles]Motoh Mutsuga, Tomoyuki Abe, Yutaka Abe, et al.
Oncology|August 30, 2019
Early Relative Change in Hepatic Function with Lenvatinib for Unresectable Hepatocellular CarcinomaAtsushi Hiraoka, Takashi Kumada, Masanori Atsukawa, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|October 30, 2019
Safety and efficacy of lenvatinib in elderly patients with unresectable hepatocellular carcinoma: A multicenter analysis with propensity score matchingToshifumi Tada, Takashi Kumada, Atsushi Hiraoka, et al.
Pageof 31